These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12664576)

  • 1. Modulation of cyclooxygenase-2 expression by APC in HT-29 human colorectal carcinoma cells.
    Hsi LC; Angerman-Stewart J; Eling TE
    Adv Exp Med Biol; 2002; 507():127-31. PubMed ID: 12664576
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
    Kennedy BP; Soravia C; Moffat J; Xia L; Hiruki T; Collins S; Gallinger S; Bapat B
    Cancer Res; 1998 Feb; 58(3):500-3. PubMed ID: 9458096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level.
    Hsi LC; Angerman-Stewart J; Eling TE
    Carcinogenesis; 1999 Nov; 20(11):2045-9. PubMed ID: 10545404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
    Buecher B; Heymann MF; Blottière HM
    Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
    Oshima M; Dinchuk JE; Kargman SL; Oshima H; Hancock B; Kwong E; Trzaskos JM; Evans JF; Taketo MM
    Cell; 1996 Nov; 87(5):803-9. PubMed ID: 8945508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inducible prostaglandin biosynthetic enzyme, cyclooxygenase 2, is not mutated in patients with attenuated adenomatous polyposis coli.
    Spirio LN; Dixon DA; Robertson J; Robertson M; Barrows J; Traer E; Burt RW; Leppert MF; White R; Prescott SM
    Cancer Res; 1998 Nov; 58(21):4909-12. PubMed ID: 9809998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
    Shattuck-Brandt RL; Lamps LW; Heppner Goss KJ; DuBois RN; Matrisian LM
    Mol Carcinog; 1999 Mar; 24(3):177-87. PubMed ID: 10204802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth regulation of Gardner's syndrome colorectal cancer cells by NSAIDs.
    Hughes-Fulford M; Boman B
    Adv Exp Med Biol; 1997; 407():433-41. PubMed ID: 9321987
    [No Abstract]   [Full Text] [Related]  

  • 9. [The transgenic mouse model of familial polyposis coli].
    Fehmann HC; Eissele R
    Z Gastroenterol; 1997 Nov; 35(11):1035-7. PubMed ID: 9490555
    [No Abstract]   [Full Text] [Related]  

  • 10. [Colorectal cancer and inhibition of cyclooxygenase-2].
    Geissler M; Mohr L; Blum HE
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid metabolism and APC: implications for colorectal cancer prevention.
    Watson AJ; Dubois RN
    Lancet; 1997 Feb; 349(9050):444-5. PubMed ID: 9040567
    [No Abstract]   [Full Text] [Related]  

  • 12. RNA profiling of cyclooxygenases 1 and 2 in colorectal cancer.
    Church RD; Yu J; Fleshman JW; Shannon WD; Govindan R; McLeod HL
    Br J Cancer; 2004 Sep; 91(6):1015-8. PubMed ID: 15328521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam.
    Dobbie Z; Muller PY; Heinimann K; Albrecht C; D'Orazio D; Bendik I; Müller H; Bauerfeind P
    Anticancer Res; 2002; 22(4):2215-20. PubMed ID: 12174906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate up-regulation of low-density lipoprotein receptor and cyclo-oxygenase-2 gene expression in human colorectal cells and in colorectal adenocarcinoma biopsies.
    Lum DF; McQuaid KR; Gilbertson VL; Hughes-Fulford M
    Int J Cancer; 1999 Oct; 83(2):162-6. PubMed ID: 10471521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon.
    Khan KN; Masferrer JL; Woerner BM; Soslow R; Koki AT
    Scand J Gastroenterol; 2001 Aug; 36(8):865-9. PubMed ID: 11495083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
    Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
    Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetics of colon carcinogenesis].
    Sasaki S; Watanabe T; Nagawa H
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():72-4. PubMed ID: 14574858
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells.
    Ikawa H; Kameda H; Kamitani H; Baek SJ; Nixon JB; Hsi LC; Eling TE
    Exp Cell Res; 2001 Jul; 267(1):73-80. PubMed ID: 11412039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanisms involved in colon carcinogenesis].
    Kannagi R
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():61-6. PubMed ID: 14574856
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells.
    Hsi LC; Baek SJ; Eling TE
    Exp Cell Res; 2000 May; 256(2):563-70. PubMed ID: 10772828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.